Nominee Director Services in Singapore: Navigate the 2026 CSP Act, Fit-and-Proper Tests, and Liability Risks with Mezzanine Enterprise
- Kelvin Eng
- 2 hours ago
- 5 min read
Summary
The Corporate Service Providers (CSP) Act mandates strict AML/CFT screening and heavier penalty structures.
Nominee directors must pass comprehensive fit-and-proper criteria under modern ACRA frameworks.
Mezzanine Enterprise’s professional corporate secretarial assistance protects companies from director-level liabilities.
Singapore’s status as a premier global financial centre is underpinned by its regulatory transparency and anti-money laundering frameworks.
Among these mandates, the statutory requirement for a resident director is a cornerstone of company incorporation. Under Section 145(1) of the Singapore Companies Act 1967, every company must appoint at least one director who is "ordinarily resident" in Singapore. This means that the appointed director must be a Singapore Citizen, Permanent Resident, or a qualifying work pass holder with a local residential address.
For foreign founders who want operational control but cannot immediately relocate, utilising a professional nominee director service has become the standard operational solution to fulfil the directorship requirement.
Once treated as a simple administrative formality, this foundational business practice has since become heavily scrutinised by the Accounting and Corporate Regulatory Authority (ACRA) with the introduction of the Corporate Service Providers Act 2024 (CSP Act) and the accompanying CSP Regulations 2025.
This article walks you through the CSP Act and its accompanying regulations, highlighting the extensive legal responsibilities, uncompromising qualification thresholds, and substantial liability profiles you need to account for when appointing a nominee director for your Singapore entity.
The CSP Act 2024 and Its Central Registers
The CSP Act 2024 imposed stringent statutory requirements on firms offering corporate services, mandating that they act as active gatekeepers to counter global illegal financial flows.
One of the most defining shifts is the prohibition of unregistered arrangements. Since 9 June 2025, individuals are strictly prohibited from acting as nominee directors "by way of business". The only exception to this rule is when the appointment of a nominee director is organised and executed directly by an ACRA-registered Corporate Service Provider (CSP). Bypassing this regime is a criminal offence punishable by fines of up to S$10,000.
In line with mandatory Anti-Money Laundering (AML) and Countering the Financing of Terrorism (CFT) checks on ultimate beneficial owners (UBOs), this regulation enforces full public transparency. This means your appointed nominee director must formally disclose their status, which is now explicitly displayed on your company’s public ACRA business profile.
Furthermore, your company must maintain an updated internal Register of Nominee Directors (ROND) and Register of Nominee Shareholders (RONS) within seven days of any change. Additionally, you must align this data with ACRA's central registers within the next two business days.
Shifting the Compliance Burden with a Fit-and-Proper Test
To ensure the integrity of these public disclosures, the CSP Regulations 2025 shifted the burden of verification squarely onto CSPs. Before arranging any appointment, a registered CSP must comprehensively evaluate and satisfy itself that the candidate passes a rigorous Fit-and-Proper Test.
This assessment tests the following critical metrics:
Financial & Legal Integrity: The candidate cannot be an undischarged bankrupt and must have zero convictions involving fraud or dishonesty, whether in Singapore or abroad.
Regulatory Conduct: The individual’s previous conduct and compliance history are closely evaluated.
Competency and Capacity Risk: ACRA and CSPs actively track concurrent directorships. Stacking 200+ companies onto a single nominee—a common practice in the past—is now a major regulatory compliance failure, as the nominee is deemed to lack the capacity to fulfil their obligations.
Crucially, a CSP that fails to perform a defensible Fit-and-Proper test faces severe financial sanctions, with corporate fines reaching up to S$100,000 per breach.
To mitigate this exposure, onboarding processes have become significantly more rigorous, with business owners expected to provide extensive documentation. This includes:
Certified passport copies
Detailed source-of-funds proofs
Access agreement granting the nominee unrestricted visibility into bank statements and accounting records
Understanding the Legal Liability of a Nominee Director
A common misconception among foreign business owners is that a nominee director is a silent figurehead with zero personal exposure. Under Singapore common law and the Companies Act 1967, there is no legal distinction between a nominee director and a standard executive director.
A nominee director carries the full breadth of fiduciary responsibilities and is personally exposed to significant legal liabilities if the company breaches statutory boundaries such as:
Statutory Compliance Defaults: Nominee directors are bound to act honestly and use reasonable diligence (Section 157), and must declare any conflicts of interest (Section 156).
Should your company fail to lodge Annual Returns (AR) or miss Annual General Meetings (AGMs), the nominee director is jointly liable and will be subject to direct court summons, fines, and even outright disqualification under Sections 154 and 155 of the Companies Act.
Tax Non-Compliance: In cases of corporate tax evasion or systemic failure to remit Goods & Services Tax (GST), the Inland Revenue Authority of Singapore (IRAS) holds resident directors personally accountable.
Insolvency and Insolvent Trading: If your business continues to incur commercial liabilities while structurally insolvent, the resident nominee director can face personal, unlimited financial liability for those debts.
Given that the nominee director carries substantial risk to their professional reputation and personal liberty, premium CSPs enforce a strict risk-mitigation framework. This is typically structured through a comprehensive Deed of Indemnity and a refundable Security Deposit (commonly between S$2,000 and S$5,000) that aligns risk management and guarantees corporate integrity.
Premium vs. Budget CSPs: Which Should You Choose When Engaging Nominee Director Services in Singapore?
While the CSP market in Singapore has many low-cost, automated corporate secretarial platforms offering nominee directorships at cut-rate prices, employing one of these shortcut services introduces unacceptable systemic risks to your international expansion. This is especially true under the strict oversight of the post-2025 CSP Act regime.
Cheap automated providers frequently rely on offshore staff who lack deep Singapore regulatory knowledge and often appoint over-extended individuals holding hundreds of concurrent directorships.
Under current regulations, no reputable CSP can profitably onboard a nominee director at cut-rate prices given the extensive costs of mandatory fit-and-proper checks and ongoing monitoring. If a cut-rate nominee director faces an inquiry or disqualification due to a compliance failure in one unrelated client company, every single entity associated with that director will be subject to immediate regulatory disruption, including frozen corporate bank accounts and sudden ACRA audits.
Appoint a Nominee Director with 100% Compliance via Mezzanine Enterprise
To navigate this complex regulatory terrain, Mezzanine Enterprise provides a professional, human-led corporate infrastructure alternative backed by a full-service law firm. We deliver 100% Singapore-based legal and corporate expertise with zero chatbot barriers, protecting your business from director-level liabilities.
